Company & Sponsor Intelligence

University of Rochester

Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.

Request enterprise analysis →

Indexed trials15

Recruiting4

Completed10

Countries1

Therapeutic footprint

alzheimersautismdepressionhuntingtonsintellectual_disabilityneuro_oncologyother_neurologyother_psychiatryparkinsons

Indexed studies

NCT04887129Testing for COVID-19 in High Risk Children With Intellectual and Developmental Disabilities (COV-IDD)
intellectual_disability · United StatesNA

NCT00076492NINDS Parkinson's Disease Neuroprotection Trial of CoQ10 and GPI 1485
parkinsons · United StatesPHASE2

NCT04201834Risperidone for the Treatment of Huntington's Disease Involuntary Movements
huntingtons · United StatesPHASE2

NCT07075965Calcium Channel Blocker in Myotonic Dystrophy Type 1
other_neurology · PHASE1

NCT00090428Diet and Behavior in Young Children With Autism
autism · United StatesPHASE1

NCT07290387Tele-Savvy for Latino Caregivers
alzheimers · United StatesNA

NCT00449865NET-PD LS-1 Creatine in Parkinson's Disease
parkinsons · United StatesPHASE3

NCT00844753Atomoxetine, Placebo and Parent Management Training in Autism
autism · United StatesPHASE4

NCT02803749Buspirone in Parkinson's Disease
parkinsons · United StatesPHASE2

NCT00278811Emergency Linkage to Outpatient Psychiatric Services
other_psychiatry · United StatesPHASE1

NCT03681015Wearable Assessments in the Clinic and Home in PD
parkinsons · United StatesCOMPLETED

NCT04390906A Study of Cognitive Changes in Patients Receiving Brain Radiation
neuro_oncology · United StatesACTIVE_NOT_RECRUITING

Intelligence layer updated: 2026-10-29 06:17:44.639239+00:00

Enterprise intelligence

Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.

Request comparative intelligence →